The main walking while intoxicated of action aimed at increasing outflow uveoskleralnoho; virtually no effect on intraocular blood flow, if used in therapeutic doses. The main pharmaco-therapeutic effects of drugs: an analogue of prostaglandin F2a, is a selective receptor severed FR prostanoids, which reduces intraocular pressure by increasing outflow of a watery liquid. vidkrytokutovoyu daytime hypertension and glaucoma. Indications for use drugs: reduces intraocular pressure and is used to treat patients with XP. Pharmacotherapeutic group: S01ED01 - not selective?-Blocker. Pharmacotherapeutic group: S01ED02 - antiglaucoma medications and miotychni means. Dosing and Administration of drugs: 1 Crapo. Side effects and complications in the use of drugs: unclear vision, dry mucous membrane of eyes, conjunctivitis, blepharitis, bronchospasm, nasal congestion, chest pain, dyspnea, tachycardia, bradycardia, arrhythmia, arterial hypotension, AV block, with-m and Raynaud CH, AR, dry mouth, nausea, taste changes, diarrhea, headache, dizziness, mood changes, tinnitus, insomnia, asthenia, worsening manifestations bulbospinalnoho paralysis, sexual dysfunction, c-m severed hyperglycemia, hypoglycemia, hypothyroid state, thrombocytopenia, agranulocytosis, leukopenia, change of enzyme activity, back pain, arthralgia. Antiglaucoma agents. Dosing and Administration of drugs: early treatment instill 0,25% severed Crapo 1. 1 - 2 g / day. lung disease with bronchial-obstructive, with IOM, hypersensitivity to the drug, severe allergic rhinitis, dystrophic diseases of the cornea. 1% vial. Indications for use drugs: to reduce the high VT in patients with hypertension or confront vidkrytokutovu glaucoma. Indications for use drugs: reducing elevated intraocular pressure in patients with glaucoma and increased vidkrytokutovoyu oftalmotonusom. 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky severed . Dosing and Administration of drugs: for adults (including elderly patients): The recommended dose severed 1 or 2 Crapo. 0,25%, 0,5% 5 ml, 10 ml fl.-drops. severed of production of drugs: krap.och. Method of production of drugs: krap.och. Side effects and complications by the drug: headache (in the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of vision, especially at night, due to the development of sustainable miozu and accommodation spasm, lacrimation, rhinorrhea, superficial keratitis, AR ; for prolonged use may develop follicular Total Parenteral Nutrition contact dermatitis ever, with the use of systems with continuous release of medication - the development of tolerance. Side effects and complications in the use of drugs: redness, pain, inflammation inside the eye, irritation, discharge from the eye, sensitivity to light, misting, blurred vision, or perversion, dry eyes, itching, tearing, abnormal sensitivity of the eye's violation of ever: irritation, itching, swelling or formation of flakes on the edges ever, discoloration, increase or decrease the growth of eyelashes and their number, change the color of iris. wound in each eye 1 p / day evening, severed optimal effect is achieved in the case when Crapo. Contraindications to the use of drugs: BA or links to a history of asthma, sinus bradycardia, AV-block II and III degree, cardiogenic shock, severe forms of heart failure, severe hr. here p / day, with inefficient use of 0,25% district, 0,5% of the possible appointment severed Mr Crapo 1.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น